We previously showed that pancreatic -cells express neuronal nitric oxide synthase (nNOS) that controls insulin secretion through two catalytic activities: nitric oxide (NO) production and cytochrome c reductase activity. We now provide evidence that the endogenous protein inhibitor of nNOS (PIN) is expressed in rat pancreatic islets and INS-1 cells. Double-immunofluorescence studies showed a colocalization of PIN with both nNOS and myosin Va in insulin-secreting -cells. Electron microscopy studies confirmed that PIN is mainly associated with insulin secretory granules and colocated with nNOS in the latter. In addition, PIN overexpression in INS-1 cells enhanced glucoseinduced insulin secretion, which is only partly reversed by addition of an NO donor, sodium nitroprusside (SNP), and unaffected by the inhibitor of cytochrome c reductase activity, miconazole. In contrast, the pharmacological inhibitor of nNOS, N-nitro-L-arginine methyl ester, amplified glucose-induced insulin secretion, an effect insensitive to SNP but completely normalized by the addition of miconazole. Thus, PIN insulinotropic effect could be related to its colocalization with the actin-based molecular motor myosin Va and as such be implicated in the physiological regulation of glucose-induced insulin secretion at the level of the exocytotic machinery. Diabetes 55: 3279 -3288, 2006 T he second messenger nitric oxide (NO) is synthesized from L-arginine by a family of enzymes known as NO synthases (NOSs). Three NOS isoforms have been identified, including the constitutive neuronal NO synthase (nNOS), endothelial NOS (eNOS), and the cytokine-inducible NOS (iNOS) (1). Constitutive NOSs produce small amounts of NO, implicated in physiological functions such as synaptic transmission (2) and vascular tone (3), whereas iNOS produces high amounts of NO, acting as a cytotoxic mediator in immune response (4). In addition to these beneficial roles, NO exerts deleterious effects as a result of its overproduction, leading to neuronal death during brain ischemia and certain neurodegenerative pathologies (5) and to autoimmune diseases (6). For these reasons, a tight regulation of NOS catalytic activity is essential for its physiological function. Modulation of iNOS expression by cytokines is believed to be the most important component of iNOS regulation, but posttranscriptional mechanisms also operate (7,8). As for the constitutive isoforms, catalytic activity is closely modulated by different mechanisms. The enzyme's activity is first controlled by the reversible binding of Ca 2ϩ -calmodulin (9), which allows the transfer of NADPH-derived electrons from the reductase to the oxygenase domain of the enzyme (10). It is also positively or negatively regulated through phosphorylation by various protein kinases such as cAMP-dependent protein kinase and protein kinase C (11,12). In addition to the role of intracellular Ca 2ϩ levels and protein kinases, constitutive NOSs are also regulated via protein-protein interactions. Thus, eNOS-associated protein-1 (ENAP-1...